- Home
- HUBC vs PYPD Comparison
HUBC vs PYPD Comparison
Compare HUBC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- PYPD
- Stock Information
- Founded
- HUBC 2017
- PYPD 2008
- Country
- HUBC Israel
- PYPD Israel
- Employees
- HUBC N/A
- PYPD N/A
- Industry
- HUBC
- PYPD Medical/Dental Instruments
- Sector
- HUBC
- PYPD Health Care
- Exchange
- HUBC Nasdaq
- PYPD Nasdaq
- Market Cap
- HUBC 16.0M
- PYPD 16.3M
- IPO Year
- HUBC N/A
- PYPD 2020
- Fundamental
- Price
- HUBC $0.52
- PYPD $3.51
- Analyst Decision
- HUBC
- PYPD Buy
- Analyst Count
- HUBC 0
- PYPD 2
- Target Price
- HUBC N/A
- PYPD $12.00
- AVG Volume (30 Days)
- HUBC 667.0K
- PYPD 5.2K
- Earning Date
- HUBC 10-15-2024
- PYPD 11-06-2024
- Dividend Yield
- HUBC N/A
- PYPD N/A
- EPS Growth
- HUBC N/A
- PYPD N/A
- EPS
- HUBC N/A
- PYPD N/A
- Revenue
- HUBC $42,657,000.00
- PYPD N/A
- Revenue This Year
- HUBC N/A
- PYPD N/A
- Revenue Next Year
- HUBC N/A
- PYPD N/A
- P/E Ratio
- HUBC N/A
- PYPD N/A
- Revenue Growth
- HUBC N/A
- PYPD N/A
- 52 Week Low
- HUBC $0.44
- PYPD $2.95
- 52 Week High
- HUBC $9.40
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- HUBC 47.35
- PYPD 50.62
- Support Level
- HUBC $0.49
- PYPD $3.31
- Resistance Level
- HUBC $0.67
- PYPD $3.62
- Average True Range (ATR)
- HUBC 0.06
- PYPD 0.17
- MACD
- HUBC 0.00
- PYPD 0.01
- Stochastic Oscillator
- HUBC 37.82
- PYPD 51.25
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.